{"id":"tp-52968","type":"article-newspaper","title":"IGC Pharma Reports $0.32 Million in Third-Quarter Revenue","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/52968","datePublished":"2026-11-10T09:42:20.000Z","dateModified":"2026-11-10T09:42:20.000Z","language":"en","abstract":"Net loss attributable to common stockholders widened to $2.046 million from $1.821 million, while basic and diluted loss per share was 2 cents.","section":"Business","references":[]}